蓝丰生化(002513.SZ)发布前三季度业绩，归母净亏损7718.21万元

Core Viewpoint - Bluefeng Biochemical (002513.SZ) reported a revenue of 1.83 billion yuan for the first three quarters of 2025, reflecting a year-on-year growth of 28.26%. However, the company recorded a net loss attributable to shareholders of 77.18 million yuan, with a net loss of 79.47 million yuan after excluding non-recurring gains and losses [1] Financial Performance - The company achieved an operating income of 1.83 billion yuan in the first three quarters of 2025 [1] - Year-on-year revenue growth was reported at 28.26% [1] - The net loss attributable to shareholders was 77.18 million yuan [1] - The net loss after excluding non-recurring gains and losses was 79.47 million yuan [1]